Advanced Search
Article Contents
ABOUT THIS ARTICLE
The Innovation Oncology > 2026 Vol. 1 > No. 2 > 100022
Next Article Previous Article
TRANSLATIONAL PATENT   Open Access     Cite

Targeting SQLE with ellagic acid and terbinafine: A low-cost, synergistic therapeutic strategy for bladder and lung cancer

  • 1.

    NHC Key Laboratory of Molecular Probes and Targeted Diagnosis and Therapy, The Fourth Hospital of Harbin Medical University, Harbin 150001, China

More Information
  • Corresponding authors: liudb@126.com (D.L.); 1280289406@qq.com (C.Z.)
  • Received Date:  April 22, 2026
    Accepted Date:  July 17, 2026
    Published Online:  July 20, 2026
The Innovation Oncology  1(2),  https://doi.org/10.59717/j.xinn-oncol.2026.100022  |  Cite this article
    • FullText(HTML)
  • 加载中
    • REFERENCES
  • [1] Siegel R.L., Kratzer T.B., Wagle N.S., et al. (2026). Cancer statistics, 2026. CA Cancer J. Clin. 76:e70043. DOI:10.3322/caac.70043

    View in Article CrossRef Google Scholar

    [2] Huang Q., Li Y., Huang Y., et al. (2025). Advances in molecular pathology and therapy of non-small cell lung cancer. Signal Transduct. Target Ther. 10:186. DOI:10.1038/s41392-025-02243-6

    View in Article CrossRef Google Scholar

    [3] Dong Y., Jiang X., Yang X., et al. (2025). SQLE drives bladder cancer progression by boosting mitochondrial oxidative phosphorylation. Oncogene 44:4796−4813. DOI:10.1038/s41388-025-03626-3

    View in Article CrossRef Google Scholar

    [4] Liu D., Wong C.C., Zhou Y., et al. (2021). Squalene epoxidase induces nonalcoholic steatohepatitis via binding to carbonic anhydrase III and is a therapeutic target. Gastroenterology 160:2467−2482.e2463. DOI:10.1053/j.gastro.2021.02.051

    View in Article CrossRef Google Scholar

    [5] Li M.T., Liu L.L., Zhou Q., et al. (2022). Phyllanthus Niruri L. Exerts protective effects against calcium oxalate-induced renal injury via ellagic acid. Front. Pharmacol. 13:891788. DOI:10.3389/fphar.2022.891788

    View in Article CrossRef Google Scholar

    • Cited by

  • Cite this article:

    Zhang Q., Zhang Y., Zhang C., et al. (2026). Targeting SQLE with ellagic acid and terbinafine: A low-cost, synergistic therapeutic strategy for bladder and lung cancer. The Innovation Oncology 1:100022. https://doi.org/10.59717/j.xinn-oncol.2026.100022
    Zhang Q., Zhang Y., Zhang C., et al. (2026). Targeting SQLE with ellagic acid and terbinafine: A low-cost, synergistic therapeutic strategy for bladder and lung cancer. The Innovation Oncology 1:100022. https://doi.org/10.59717/j.xinn-oncol.2026.100022

Welcome!

To request copyright permission to republish or share portions of our works, please visit Copyright Clearance Center's (CCC) Marketplace website at marketplace.copyright.com.

PDF
Figures(1)    

Share

  • Share the QR code with wechat scanning code to friends and circle of friends.

Article Metrics

Article views(95) PDF downloads(37)

Relative Articles

Cited by

Catalog

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return

    {{newsColumn.name}}

    {{newsColumn.name}}

    Stay connected

    {{newsColumn.name}}

    Website copyright © Innovation Press. Published articles are licensed under CC BY with copyright retained by the authors.